💊Fujifilm accelerates new drug development for diagnostic and therapeutic drugs through the merger of group companies to form FUJIFILM Toyama Chemical Co., Ltd.

By Drugs, Pharmaceutical

💊Fujifilm accelerates new drug development for diagnostic and therapeutic drugs through the merger of group companies to form FUJIFILM Toyama Chemical Co., Ltd.

May 14, 2018
FUJIFILM Holdings
FUJIFILM Holdings Corporation (President: Kenji Sukeno) today announced it plans to merge TOYAMA CHEMICAL CO., LTD., a company that conducts the research, development, manufacture, and sales of small molecule pharmaceutical products, and FUJIFILM RI Pharma Co., Ltd., a company that conducts the research, development, manufacture, and sales of radiopharmaceuticals, to form FUJIFILM Toyama Chemical Co., Ltd. as of October 1, 2018 in order to accelerate the development of new diagnostic and therapeutic drugs.

FUJIFILM Holdings

http://www.fujifilmholdings.com/en/news/2018/0514_01_01.html

More from tokioX :

  1. COVID-19: Shionogi supplies S-217622 to the Japanese government: Corona oral remedy
  2. COVID-19: Japanese corona drug: S-217622 clinical trial started
  3. EVA Pharma to Start Manufacturing Antiviral Drug Favipiravir
  4. Is this America’s most hated family?
  5. 🍀Fujifilm to acquire Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.
  6. 💊Production of Liposome Drugs Utilizing Proprietary Technologies Including Anti-Cancer Agent FF-10832 New Manufacturing Facility to be Built at Toyama Chemical, a Fujifilm Company
  7. 💊Fujifilm acquires equity stake in EdiGene, a drug discovery startup.